GU Cancers 2019 | UCLA-UroCCR collaborative study on sRCC: identifying pathogenic factors
Cedric Lebacle, of the University of Paris-Sud, Orsay, France, discusses the results from a collaborative study carried out by French UroCCR and UCLA, investigating the clinical predictors of sarcomatoid renal cell carcinoma (sRCC). Speaking at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, Dr Lebacle reports that active smoking was a predictor significantly associated with the presence of sRCC.
Transcript (edited for clarity):
My other project was a collaboration between French group, Euro CCR, and UCLA group. I breed a collaboration to add the French patient with a sarcomatoid tumor to the UCLA patient with sarcomatoid tumor.
Like that, I could predict, clinical factor, we can predict a presence of sarcomatoid tumors features on pheno-pathology.
So, the main, the main factor, could influence the presence of sarcomatoid in the pathology with the current smoker. Patient who will smoke before the surgery has better risk to get sarcomatoid tumors on the pathology.
Get great new content delivered to your inboxSign up